mCherry-CRY2–mPKCε-CAT-HA
(Plasmid
#190483)
-
PurposeExpresses a fluorescently-tagged, optogenetically activated PKC-epsilon. Used in tandem with CIBN-CAAX
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 190483 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepmCherry-C1
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namemCherry-CRY2–mPKCε-CAT-HA
-
SpeciesM. musculus (mouse), Synthetic
-
Insert Size (bp)3418
-
Entrez GenePrkce (a.k.a. 5830406C15Rik, PKC[e], PKCepsilon, Pkce)
- Promoter CMV
-
Tags
/ Fusion Proteins
- mCherry (N terminal on insert)
- HA (C terminal on insert)
- Fused to CRY2 (N terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site Nhe1 (not destroyed)
- 3′ cloning site Sma1 (not destroyed)
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH-R (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
mCherry-CRY2–mPKCε-CAT-HA was a gift from Diomedes Logothetis (Addgene plasmid # 190483 ; http://n2t.net/addgene:190483 ; RRID:Addgene_190483) -
For your References section:
An optogenetic tool to recruit individual PKC isozymes to the cell surface and promote specific phosphorylation of membrane proteins. Gada KD, Kawano T, Plant LD, Logothetis DE. J Biol Chem. 2022 May;298(5):101893. doi: 10.1016/j.jbc.2022.101893. Epub 2022 Mar 31. 10.1016/j.jbc.2022.101893 PubMed 35367414